Please login to the form below

Not currently logged in
Email:
Password:

BI

This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.

Boehringer beefs up biologics capacity with €230m investment

Boehringer beefs up biologics capacity with €230m investment

CD40 antibody BI 655064 in phase II for lupus nephritis. ... Following after in earlier-stage development are a first-in-class IL-36 receptor inhibitor BI 655130 for pustular psoriasis and other immune diseases, and an array of vaccines, oncoytic viruses

Latest news

More from news
Approximately 4 fully matching, plus 86 partially matching documents found.

Latest Intelligence

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our

  • Is it time we stopped talking about adherence? Is it time we stopped talking about adherence?

    attractive and valuable bi-product.

  • Deal Watch September 2016 Deal Watch September 2016

    Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody

  • The human perspective The human perspective

    But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI

  • Deal Watch April 2016 Deal Watch April 2016

    1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest from PMHub

  • Infographic: HIV Market Snapshot

    Therapy Watch HIV patient data is collected bi-monthly from a panel of 150 physicians across the main 5 EU markets and 100 physicians in the US.

  • Box Bear Ltd

    Box Bear Ltd. A boutique agency punching above its weight. Prefered suppliers of GSK, Roche, Shire and BI to name a few, working directly or with partners to deliver animation, video,

  • Frontera

    Gold - Caphosol sales aid - Sales aid. Gold - BI interactive video - Interactive communications.

  • Frontera

    Gold - Caphosol sales aid - Sales aid. Gold - BI interactive video - Interactive communications.

  • PharmiWeb Solutions Support Cancer Charity

    This inaugural PharmiWeb Solutions “ Bake a Smile” event raised £200.00 on the day, with bi-weekly events already in the diary throughout the rest of 2014, and with Christopher’ s

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics